CDDO-TFEA (RTA 404, TP-500) is a trifluoroacetamide derivative of CDDO with enhanced ability to cross the blood-brain barrier. CDDO is an Nrf2 activator that inhibits proliferation and induces differentiation and apoptosis in various cancer cells. CDDO-TFEA can enhance Nrf2 expression and signaling in various neurodegenerative disease models.
Molekulargewicht:
572.7
Reinheit:
>98.0%
CAS Nummer:
[932730-52-4]
Formel:
C33H43F3N2O3
Target-Kategorie:
Keap1-Nrf2
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten